The role of triterpenes in the management of diabetes mellitus and its complications

Phytochemistry Reviews

Volumn 14, Issue 4, 2015, Pages 675-690

  Nazaruk, J ^a   Borzym Kluczyk, M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Diabetes mellitus; Natural products; Triterpenes

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 2,3 SECO 2' (29)LUPENE 2,3 DIOIC ACID; 3 BETA ,22 ALPHA DIHYDROXYOLEAN 12 EN 29 OIC ACID; ALDEHYDE REDUCTASE; ALPHA AMYRIN 3 O BETA (5 HYDROXY)FERULIC ACID; ALPHA GLUCOSIDASE; AMYLASE; ANTIDIABETIC AGENT; ARJUNOIC ACID; COROSOLIC ACID(1 HYDROXYURSOLIC ACID); G PROTEIN COUPLED RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN PHOSPHORYLASE; GYMNEMIC ACID; HEDERAGENIN; ILEKUDINOL A; ILEKUDINOL B; KOTALAGENIN 16 ACETATE; MAYTENFOLIC ACID; OLEANANE DERIVATIVE; OLEANOLIC ACID; PARA COUMAROYLURSOLIC ACID; PISTAGREMIC ACID; PROTEIN TYROSINE PHOSPHATASE 1B; TERPENOID SWEETNESS INHIBITOR; TGR5 RECEPTOR; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSANE DERIVATIVE; URSOLIC ACID;

ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; DRUG TOXICITY; EMBRYOPATHY; ENZYME INHIBITION; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN SYNTHESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STRUCTURE ACTIVITY RELATION; WOUND HEALING IMPAIRMENT;

EID: 84938954830     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-014-9369-x     Document Type: Review

References (97)

1. Ahmed N (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 67:3–21
2. Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C, Rönquist-Nii Y, Öhman B, Abrahmsén L (2002) Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45:1528–1532
3. Ali MS, Jahangir M, ul Hussan SS, Choudhary MI (2002) Inhibition of α-glucosidase by oleanolic acid and its synthetic derivatives. Phytochemistry 60:295–299
4. Ali H, Houghton PJ, Soumyanath A (2006) α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 107:449–455
5. Ardiles AE, González-Rodríguez Á, Núñez MJ, Perestelo NR, Pardo V, Jiménez IA, Valverde ÁM, Bazzocchi IL (2012) Studies of naturally occurring friedelane triterpenoids as insulin sensitizers in the treatment type 2 diabetes mellitus. Phytochemistry 84:116–124
6. Atanasov AG, Dzyakanchuk AA, Schweizer RAS, Nashev LG, Maurer EM, Odermatt A (2006) Coffee inhibits the reactivation of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1: a glucocorticoid connection in the anti-diabetic action of coffee? FEBS Lett 580:4081–4085
7. Baker DJ, Timmons JA, Greenhaff PL (2005) Glycogen phosphorylase inhibition in type 2 diabetes therapy. A systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes 54:2453–2459
8. Baltina LA, Flekhter OB, Nigmatullina LR, Boreko EI, Pavlova NI, Nikolaeva SN, Savinova OV, Tolstikov GA (2003) Lupane triterpenes and derivatives with antiviral activity. Bioorg Med Chem Lett 13:3549–3552
9. Ban CR, Twigg SM (2008) Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag 4:575–596
10. Basta G, Schmidt AM, De Caterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582–592
11. Blum A, Favia AD, Maser E (2009) 11β-hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds. Mol Cell Endocrinol 301:132–136
12. Brala PM, Hagen RL (1983) Effects of sweetness perception and caloric value of a preload on short term intake. Physiol Behav 30:1–9
13. Cerga O, Borcan F, Ambrus R, Popovici I (2011) Syntheses of new cyclodextrin complexes with oleanolic and ursolic acids. J Agroaliment Proc Technol 17:405–409
14. Chen X, Lou G, Meng Z, Huang W (2011) TGR5: a novel target for weight maintenance and glucose metabolism. Exp Diabetes Res. Article ID 853501
15. Cheng HM, González RG (1986) The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. Metabolism 35:10–14
16. Choi YH, Zhou W, Oh J, Choe S, Kim DW, Lee SH, Na MK (2012) Rhododendric acid A, a new ursane-type PTP1B inhibitor from the endangered plant Rhododendron brachycarpum G. Don. Bioorg Med Chem Lett 22:6116–6119
17. de Sales PM, Monteiro de Souza P, Alberto Simeoni L, de Oliveira Magalhães P, Silveira D (2012) α-Amylase inhibitors: a review of raw material and isolated compounds from plant source. J Pharm Pharmaceut Sci 15:141–183. www.cspsCanada.org
18. Deutschländera MS, Lall N, Van de Venter M, Hussein AA (2011) Hypoglycemic evaluation of a new triterpene and other compounds isolated from Euclea undulata Thunb. var. myrtina (Ebenaceae) root bark. J Ethnopharmacol 133:1091–1095
19. Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599–622
20. Fröde TS, Medeiros YS (2008) Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol 115:173–183
21. Genet C, Strehle A, Schmidt C, Boudjelal G, Lobstein A, Schoonjans K, Souchet M, Auwerx J, Saladin R, Wagner A (2010a) Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes. J Med Chem 53:178–190
22. Genet C, Schmidt C, Strehle A, Schoonjans K, Auwerx J, Saladin R, Wagner A (2010b) Redefining the TGR5 triterpenoid binding pocket at the C-3 position. ChemMedChem 5:1983–1988
23. Ghosh T, Maity TK, Singh J (2011) Antihyperglycemic activity of bacosine, a triterpene from Bacopa monnieri, in alloxan-induced diabetic rats. Planta Med 77:804–808
24. Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products sparking the development of diabetic vascular injury. Circulation 114:597–605
25. Goldstein BJ (2002) Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. J Clin Endocrinol Metab 87:2474–2480
26. Gowri PM, Tiwari AK, Ali AZ, Rao JM (2007) Inhibition of α-glucosidase and amylase by bartogenic acid isolated from Barringtonia racemosa Roxb. seeds. Phytother Res 21:796–799
27. Guan T, Qian Y, Tang X, Huang M, Huang L, Li Y, Sun H (2011) Maslinic acid, a natural inhibitor of glycogen phosphorylase, reduces cerebral ischemic injury in hyperglycemic rats by GLT-1 up-regulation. J Neurosci Res 89:1829–1839
28. Harborne JB, Baxter H (1993) Phytochemical dictionary. A handbook of bioactive compounds from plants. Taylor & Francis, London, pp 728–738
29. Hou W, Li Y, Zhang Q, Wei X, Peng A, Chen L, Wei Y (2009) Triterpene acids isolated from Lagerstroemia speciosa leaves as α-glucosidase inhibitors. Phytother Res 23:614–618
30. Huang Y-C, Chang W-L, Huang S-F, Lin C-Y, Lin H-C, Chang T-C (2010) Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation. Eur J Pharmacol 648:39–49
31. Ishijima S, Takashima T, Ikemura T, Izutani Y (2008) Gymnemic acid interacts with mammalian glycerol-3-phosphate dehydrogenase. Mol Cell Biochem 310:203–208
32. Jäger S, Trojan H, Kopp T, Laszczyk MN, Scheffler A (2009) Pentacyclic triterpene distribution in various plants–rich sources for a new group of multi-potent plant extracts. Molecules 14:2016–2031
33. Jang S-M, Yee S-T, Choi J, Choi M-S, Do G-M, Jeon S-M, Yeo J, Kim M-J, Seo K-I, Lee M-K (2009) Ursolic acid enhances the cellular immune system and pancreatic β-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int Immunopharmacol 9:113–119
34. Jiang B, Yang Y, Jin H, Shang W, Zhou L, Qian L, Chen M (2008) Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFα in 3T3-L1 adipocytes. Phytother Res 22:1434–1439
35. Judy WV, Hari SP, Stogsdill WW, Judy JS, Naguib YMA, Passwater R (2003) Antidiabetic activity of a standardized extract (Glucosol™) from Lagerstroemia speciosa leaves in Type II diabetics. A dose-dependence study. J Ethnopharmacol 87:115–117
36. Jung SH, Ha YJ, Shim EK, Choi SY, Jin JL, Yun-Choi HS, Lee JR (2007) Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator. Biochem J 403:243–250
37. Keller AC, Ma J, Kavalier A, He K, Brillantes A-MB, Kennelly EJ (2011) Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine 19:32–37
38. Kuang H-X, Li H-W, Wang Q-H, Yang B-Y, Wang Z-B, Xia Y-G (2011) Triterpenoids from the roots of Sanguisorba tenuifolia var. alba. Molecules 16:4642–4651
39. Kwon J-H, Chang M-J, Seo H-W, Lee J-H, Min B-S, Na MK, Kim JC, Woo MH, Choi JS, Lee HK, Bae KH (2008) Triterpenoids and a sterol from the stem-bark of Styrax japonica and their protein tyrosine phosphatase 1B inhibitory activities. Phytother Res 22:1303–1306
40. Lai Y-C, Chen C-K, Tsai S-F, Lee S-S (2012) Triterpenes as α-glucosidase inhibitors from Fagus hayatae. Phytochemistry 74:206–211
41. Laszczyk MN (2009) Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med 75:1549–1560
42. Lee M-S, Hwang J-T, Kim S-H, Yoon S, Kim M-S, Yang HJ, Kwon DY (2010) Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. J Ethnopharmacol 127:771–776
43. Li T-H, Hou C-C, Chang CL-T, Yang W-C (2011) Anti-hyperglycemic properties of crude extract and triterpenes from Poria cocos. Evid base Compl Altern Med. Article ID 128402
44. Lipson VV, Zamigajlo LL, Petrova ON (2011) Development of 11β-HSD1 inhibitors for the treatment of metabolic syndrome. Ukr Bioorg Acta 2:3–13
45. Liu J, Sun H, Duan W, Mu D, Zhang L (2007) Maslinic acid reduces blood glucose in KK-Ay mice. Biol Pharm Bull 30:2075–2078
46. Liu J, He T, Lu Q, Shang J, Sun H, Zhang L (2010) Asiatic acid preserves beta cell mass and mitigates hyperglycemia in streptozocin-induced diabetic rats. Diabetes Metab Res Rev 26:448–454
47. Lü H, Chen J, Li WL, Ren BR, Wu JL, Kang HY, Zhang HQ, Adams A, De Kimpe N (2009) Hypoglycemic and hypolipidemic effects of the total triterpene acid fraction from folium Eriobotryae. J Ethnopharmacol 122:486–491
48. Luo J-G, Liu J, Kong L-Y (2008) New pentacyclic triterpenes from Gypsophila oldhamiana and their biological evaluation as glycogen phosphorylase inhibitors. Chem Biodivers 5:751–757
49. Lv L, Wu S-Y, Wang G-F, Zhang J-J, Pang J-X, Liu Z-Q, Xu W, Wu S-G, Rao J-J (2010) Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Phytother Res 24:219–224
50. Manna P, Sinha M, Sil PC (2009) Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades. Chem Biol Interact 181:297–308
51. Manna P, Ghosh J, Das J, Sil PC (2010) Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: protective role of arjunolic acid. Toxicol Appl Pharmacol 244:114–129
52. Matsuda H, Murakami T, Jashiro K, Yamahara J, Yoshikawa M (1999) Antidiabetic principles of natural medicines. IV. Aldose reductase and α-glucosidase inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of a new friedelane-type triterpene, kotalagenin 16-acetate. Chem Pharm Bull 47:1725–1729
53. Motomura K, Fujiwara Y, Kiyota N, Tsurushima K, Takeya M, Nohara T, Nagai R, Ikeda T (2009) Astragalosides isolated from the root of Astragalus Radix inhibit the formation of advanced glycation end products. J Agric Food Chem 57:7666–7672
54. Na MK, Cui L, Min BS, Bae KH, Yoo JK, Kim BY, Oh WK, Ahn JS (2006a) Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe koreana. Bioorg Med Chem Lett 16:3273–3276
55. Na MK, Yang S, He L, Oh H, Kim BS, Oh WK, Kim BY, Ahn JS (2006b) Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata. Planta Med 72:261–263
56. Na M, Kim BY, Osada H, Ahn JS (2009) Inhibition of protein tyrosine phosphatase 1B by lupeol and lupenone isolated from Sorbus commixta. J Enzym Inhib Med Chem 24:1056–1059
57. Na MK, Thuong PT, Hwang IH, Bae KH, Kim BY, Osada H, Ahn JS (2010) Protein tyrosine phosphatase 1B inhibitory activity of 24-norursane triterpenes isolated from Weigela subsessilis. Phytother Res 24:1716–1719
58. Oikonomakos NG, Skamnaki VT, Tsitsanou KE, Gavalas NG, Johnson LN (2000) A new allosteric site in glycogen phosphorylase b as a target for drug interactions structure. Structure 8:575–584
59. Ono E, Inoue J, Hashidume T, Shimizu M, Sato R (2011) Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet. Biochem Biophys Res Commun 410:677–681
60. Petrash JM (2004) All in the family: aldose reductase and closely related aldo-ketoreductases. Cell Mol Life Sci 61:737–749
61. Rahimi R, Nikfar S, Larijani B, Abdollahi M (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 59:365–373
62. Ramachandran S, Prasad NR (2008) Effect of ursolic acid, a triterpenoid antioxidant, on ultraviolet-B radiation-induced cytotoxicity, lipid peroxidation and DNA damage in human lymphocytes. Chem Biol Interact 176:99–107
63. Ramírez-Espinosa JJ, Rios MY, López-Martínez S, López-Vallejo F, Medina-Franco JL, Paoli P, Camici G, Navarrete-Vázquez G, Ortiz-Andrade R, Estrada-Soto S (2011) Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches. Eur J Med Chem 46:2243–2251
64. Rollinger JM, Kratschmar DV, Schuster D, Pfisterer PH, Gumy C, Aubry EM, Brandstöttera S, Stuppner H, Wolber G, Odermatt A (2010) 11β-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches. Bioorg Med Chem 18:1507–1515
65. Sanchez-Gonzalez M, Lozano-Mena G, Juan ME, Garcia-Granados A, Planas JM (2013) Assessment of the safety of maslinic acid, a bioactive compound from Olea europaea L. Mol Nutr Food Res 57:339–346
66. Santos FA, Frota JT, Arruda BR, de Melo TS, da Silva AA, Brito GA, Chaves MH, Rao VS (2012) Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice. Lipids Health Dis 11:98
67. Sasaki T, Li W, Morimura H, Li S, Li Q, Asada Y, Koike K (2011) Chemical constituents from Sambucus adnata and their protein-tyrosine phosphatase 1B inhibitory activities. Chem Pharml Bull 59:1396–1399
68. Sato M, Tai T, Nunoura Y, Yajima Y, Kawashima S, Tanaka K (2002) Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharm Bull 25:81–86
69. Sato H, Genet C, Strehle A, Thomas C, Lobstein A, Wagner A, Mioskowski C, Auwerx J, Saladin R (2007) Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem Biophys Res Commun 362:793–798
70. Seo C, Yim JH, Lee HK, Oh H (2011) PTP1B inhibitory secondary metabolites from the Antarctic lichen Lecidella carpathica. Mycology 2:18–23
71. Shi L, Zhang W, Zhou Y-Y, Zhang Y-N, Li J-Y, Hu L-H, Li J (2008) Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. Eur J Pharmacol 584:21–29
72. Shih C-C, Lin C-H, Wu J-B (2010) Eriobotrya japonica improves hyperlipidemia and reverses insulin resistance in high-fat-fed mice. Phytother Res 24:1769–1780
73. Sticher O (2010) Triterpene einschließlich Steroide. In: Hänsel R, Sticher O (eds) Pharmacognosie–phytopharmazie, 9. Auflage. Springer Medizin Verlag, Heidelberg, pp 833–863
74. Stulnig TM, Waldhäusl W (2004) 11β-Hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia 47:1–11
75. Su W, Dai D-Z, Liu H-R, Na T, Dai Y (2007) Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni. Clin Exp Pharmacol Physiol 34:1228–1233
76. Sudhahar V, Kumar SA, Sudharsan PT, Varalakshmi P (2007) Protective effect of lupeol and its ester on cardiac abnormalities in experimental hypercholesterolemia. Vasc Pharmacol 46:412–418
77. Suttisri R, Lee I-S, Kinghorn AD (1995) Plant-derived triterpenoid sweetness inhibitors. J Ethnopharmacol 47:9–26
78. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH (2011) Management of type 2 diabetes: new and future developments in treatment. Lancet 378:182–197
79. Tan M-J, Ye J-M, Turner N, Hohnen-Behrens C, Ke C-Q, Tang C-P, Chen T, Weiss C-H, Gesing E-R, Rowland A, James DE, Ye Y (2008) Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15:263–273
80. Thareja S, Aggarwal S, Bhardwaj TR, Kumar M (2012) Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus. Med Res Rev 32:459–517
81. Uddin G, Rauf A, Al-Othman AM, Collina S, Arfan M, Ali A, Khan I (2012) Pistagremic acid, a glucosidase inhibitor from Pistacia integerrima. Fitoterapia 83:1648–1652
82. Ullevig SL, Zhao Q, Zamora D, Asmis R (2011) Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis 219:409–416
83. Wamil M, Seckl JR (2007) Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discov Today 12:504–520
84. Wang Z-H, Hsu C-C, Huang C-N, Yin M-C (2010) Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur J Pharmacol 628:255–260
85. Wang X, Li Y-L, Wu H, Liu J-Z, Hu J-X, Liao N, Peng J, Cao P-P, Liang X, Hai C-X (2011) Antidiabetic effect of oleanolic acid: a promising use of a traditional pharmacological agent. Phytother Res 25:1031–1040
86. Wen X, Sun H, Liu J, Wu G, Zhang L, Wu X, Ni P (2005) Pentacyclic triterpenes. Part 1: the first examples of naturally occurring pentacyclic triterpenes as a new class of inhibitors of glycogen phosphorylases. Bioorg Med Chem Lett 15:4944–4948
87. Wen X, Zhang P, Liu J, Zhang L, Wu X, Ni P, Sun H (2006) Pentacyclic triterpenes. Part 2: synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors. Bioorg Med Chem Lett 16:722–726
88. Xiang M, Wang J, Zhang Y, Ling J, Xu X (2012) Attenuation of aortic injury by ursolic acid through RAGE-Nox-NFκB pathway in streptozocin-induced diabetic rats. Arch Pharm Res 35:877–886
89. Yamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M (2006) Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 79:2474–2479
90. Yang J, Chen H, Zhang L, Wang Q, Lai M-X (2010) Anti-diabetic effect of standardized extract of Potentilla discolor Bunge and identification of its active components. Drug Dev Res 71:127–132
91. Yasukawa K, Akihisa T, Oinuma H, Kasahara Y, Kimura Y, Yamanouchi S, Kumaki K, Tamura T, Takido M (1996) Inhibitory effect of di- and trihydroxy triterpenes from the flowers of Compositae on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Biol Pharm Bull 19:1329–1331
92. Yin MC, Chan KC (2007) Nonenzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J Agric Food Chem 55:7177–7181
93. Yin M-C, Lin M-C, Mong M-C, Lin C-Y (2012) Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. J Agric Food Chem 60:7697–7701
94. Zeng X-Y, Wang Y-P, Cantley J, Iseli TJ, Molero JC, Hegarty BD, Kraegen EW, Ye Y, Ye M (2012) Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice. PLoS One 7:1–12
95. Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li J-Y, Hu L-H, LI J (2006) Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta 1760:1505–1512
96. Zhang XS, Bi X-L, Bi X-L, Wan-Xiao, Cao J-Q, Xia X-C, Diao Y-P, Zhao Y-Q (2013) Protein tyrosine phosphatase 1B inhibitory effect by dammarane-type triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins. Bioorg Med Chem Lett 23:297–300
97. Zhou Y, Li J-S, Zhang X, Wu Y-J, Huang K, Zheng L (2010) Ursolic acid inhibits early lesions of diabetic nephropathy. Int J Mol Med 26:565–570